This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Anderson, K. F.
Right arrow Articles by Patel, J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Anderson, K. F.
Right arrow Articles by Patel, J. B.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, August 2007, p. 2723-2725, Vol. 45, No. 8
0095-1137/07/$08.00+0     doi:10.1128/JCM.00015-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Evaluation of Methods To Identify the Klebsiella pneumoniae Carbapenemase in Enterobacteriaceae{triangledown}

K. F. Anderson,* D. R. Lonsway, J. K. Rasheed, J. Biddle, B. Jensen, L. K. McDougal, R. B. Carey, A. Thompson, S. Stocker, B. Limbago, and J. B. Patel

Centers for Disease Control and Prevention, Division of Healthcare Quality Promotion, Atlanta, Georgia

Received 3 January 2007/ Returned for modification 13 February 2007/ Accepted 6 June 2007


arrow
ABSTRACT
 
The Klebsiella pneumoniae carbapenem (KPC) ß-lactamase occurs in Enterobacteriaceae and can confer resistance to all ß-lactam agents including carbapenems. The enzyme may confer low-level carbapenem resistance, and the failure of susceptibility methods to identify this resistance has been reported. Automated and nonautomated methods for carbapenem susceptibility were evaluated for identification of KPC-mediated resistance. Ertapenem was a more sensitive indicator of KPC resistance than meropenem and imipenem independently of the method used. Carbapenemase production could be confirmed with the modified Hodge test.


arrow
TEXT
 
Carbapenems are commonly used to treat infections caused by multidrug-resistant Enterobacteriaceae. In the United States and other locations, an increasingly common mechanism of carbapenem resistance is the Klebsiella pneumoniae carbapenemase (KPC) (2, 10, 15, 18, 19, 24, 26, 27). The KPC ß-lactamase occurs most commonly in K. pneumoniae, but it has also been reported sporadically in other species of Enterobacteriaceae (Klebsiella oxytoca, Enterobacter spp., Escherichia coli, Salmonella spp., Citrobacter freundii, and Serratia spp.) and Pseudomonas aeruginosa (4, 10-12, 17, 23, 28). The KPC enzyme confers resistance to all ß-lactam agents including penicillins, cephalosporins, monobactams, and carbapenems (1, 21, 27, 28). Some isolates containing KPC demonstrate low-level carbapenem resistance, but when combined with other cellular changes, such as porin loss, the carbapenem MIC increases (21, 26). The gene encoding the KPC enzyme is usually flanked by transposon-related sequences and has been identified on conjugative plasmids; therefore, the potential for dissemination is significant (17, 26-28). Several outbreaks of KPC-producing bacteria have occurred in the northeast United States (2, 26). Isolates that acquired this enzyme are usually resistant to several other classes of antimicrobial agents used as treatment options. Laboratory identification of KPC-producing clinical isolates will be critical for limiting the spread of this resistance mechanism. The failure of automated susceptibility testing systems to detect KPC-mediated resistance was previously noted (5, 22).

We evaluated commonly used susceptibility testing methods to identify the most sensitive conditions for KPC detection with 31 KPC-producing Enterobacteriaceae isolates (25 of K. pneumoniae, 2 of K. oxytoca, 1 of E. coli, 1 of Enterobacter spp., 1 of Citrobacter freundii, and 1 of Salmonella spp.). These were isolated from different patients who were hospitalized in 13 different healthcare institutions from seven different states: Maryland (one), New Jersey (two), New York (four), Pennsylvania (two), Michigan (two), Missouri (one), and North Carolina (one). The presence of blaKPC was determined using previously described oligonucleotide primers and cycling conditions (27). Enzyme activity was demonstrated in all isolates by isoelectric focusing (6, 16).

To measure the specificity of methods to detect KPC-mediated resistance, 45 isolates (26 of K. pneumoniae, 9 of K. oxytoca, and 10 of E. coli) were chosen for testing. All 45 isolates were negative for blaKPC by PCR. These isolates were submitted to the CDC for reference susceptibility testing. Using the reference broth microdilution (BMD) method, all isolates met the CLSI extended-spectrum ß-lactamase (ESBL) screening test criteria; that is, they demonstrated reduced susceptibility to at least one extended-spectrum cephalosporin (7, 8). Twenty-six isolates were positive by the CLSI ESBL broth confirmatory test, and the other isolates were presumed to have another broad-spectrum ß-lactamase or other mechanism of cephalosporin resistance. Five isolates were nonsusceptible to a carbapenem (imipenem, meropenem, or ertapenem) by BMD. Since two of the isolates were ESBL producers by BMD and the other three isolates produced an AmpC-type enzyme as demonstrated by isoelectric focusing and PCR (20), it is likely that the mechanism of reduced carbapenem susceptibility is a combination of a cephaloporinase and porin loss (3, 9, 13).

Meropenem, imipenem, and ertapenem susceptibilities were determined by BMD using cation-adjusted Mueller-Hinton broth in panels that were prepared in-house (7), disk diffusion (Becton Dickinson, Sparks, MD) (8), Etest (AB Biodisk, Piscataway, NJ), Microscan Autoscan using the NM32 panel (Dade Behring, West Sacramento, CA), and the Vitek 2 test using the AST GN14 card (bioMérieux, Durham, NC). Susceptibility testing of meropenem and imipenem was performed with the Phoenix test using the NEG MIC 30 panel or NEG MIC 112 panel (Becton Dickinson, Sparks, MD), the Vitek Legacy test using the GNS-122 and GNS-127 panels (bioMérieux, Durham, NC), and the Sensititre Auto Reader using the GN2F panel (Trek Diagnostics, West Lake, OH). All methods were performed according to the manufacturers' recommendations. Quality control testing of susceptibility testing methods was performed with Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853. Two criteria were evaluated for detection of KPC-mediated resistance: (i) an intermediate or resistant susceptibility to a carbapenem or (ii) a carbapenem MIC of >1 µg/ml (see Table 1).


View this table:
[in this window]
[in a new window]

  		TABLE 1. Performance of susceptibility testing methods for detecting KPC-mediated resistance

Overall, reference BMD was the most sensitive method for the identification of KPC-mediated carbapenem resistance (Table 1). An interpretation of intermediacy or resistance for any of the three carbapenems tested (meropenem, imipenem, and ertapenem) demonstrated greater than 90% sensitivity. For disk diffusion, Etest, Vitek 2, and MicroScan greater than 90% sensitivity was achieved only when ertapenem was tested. When interpreting the results for the disk diffusion test and the Etest, it was important to recognize the presence of small colonies growing inside the zone of inhibition. Meropenem and imipenem susceptibility demonstrated poor sensitivity for methods other than BMD. However, the specificity of meropenem and imipenem susceptibility testing was higher than that for ertapenem susceptibility testing regardless of test method. For nearly all methods (i.e., those demonstrating a specificity of ≥89%), the specificity errors occurred with one or more of the five isolates that were nonsusceptible to carbapenem by a mechanism other than carbapenemase production. It is important that these are not specificity errors in measuring carbapenem susceptibility but rather errors in the detection of carbapenemase production.

Using the criterion of a carbapenem MIC of >1 µg/ml, the sensitivity of detecting KPC-mediated resistance increased for ertapenem, meropenem, and imipenem with only small changes in specificity. Meropenem susceptibility testing demonstrated greater than 90% sensitivity by BMD and MicroScan whereas imipenem susceptibility testing was at least 90% sensitive by BMD, Etest, Vitek 2, and MicroScan.

The modified Hodge test (Fig. 1) was also evaluated for detection of KPC-mediated resistance (14). This is a phenotypic test which could be used to determine if reduced susceptibility to carbapenems is mediated by a carbapenemase. The test was performed as described by Lee et al. (14), and it demonstrated 100% sensitivity and specificity for detection of KPC activity.


Figure 1
View larger version (143K):
[in this window]
[in a new window]

  		FIG. 1. The modified Hodge test Mueller-Hinton agar plate was inoculated with a 1:10 dilution of a 0.5 McFarland suspension of E. coli ATCC 25922 and streaked for confluent growth using a swab. A 10-µg imipenem disk was placed in the center, and each test isolate was streaked from the disk to the edge of the plate. Isolate A is a KPC producer and positive by the modified Hodge test. Isolates B, C, D, and E do not produce a carbapenemase and are negative by the test.

We tested a limited number of isolates in this study. The actual sensitivity and specificity of these methods in any given laboratory will depend upon the prevalent mechanisms of ß-lactam resistance in the laboratory's patient population. Considering the potential clinical impact of carbapenemase-producing isolates, laboratories should consider testing for ertapenem susceptibility since it was the most sensitive indicator of KPC activity regardless of method. Ertapenem is not available on panels from all manufacturers; laboratories that cannot test ertapenem on their current system may consider using the ertapenem disk diffusion test, which was a sensitive indicator for the presence of the KPC enzyme in this study and a study by Bratu et al. (5). The KPC enzyme also hydrolyzes extended-spectrum cephalosporins; therefore, screening for reduced susceptibility to carbapenems could be limited to isolates that are resistant to these cephalosporins (e.g., ceftazidime, ceftriaxone, and cefotaxime). Alternatively, meropenem and imipenem susceptibility could be used to detect KPC-mediated resistance if an elevated but susceptible MIC (MIC of >1 µg/ml) is applied. However, it should be noted that this MIC cutoff was applied only to Klebsiella spp. and E. coli in this study. Other species of Enterobacteriaceae have higher wild-type carbapenem MICs (www.eucast.org), and so this strategy may not be appropriate.

No method demonstrated 100% specificity for carbapenemase activity. In the United States, where metallo-ß-lactamases are uncommon, the most likely alternative mechanism of carbapenem resistance is the combination of an ESBL or AmpC-type enzyme with porin loss (3, 9, 13). A report by Woodford et al. (25) noted that nonsusceptibility to ertapenem is not specific for carbapenemase production, especially when carbapenemase production is uncommon. Also, the authors noted that for isolates with noncarbapenemase mechanisms, ertapenem resistance does not necessarily predict resistance to other carbapenems. In this study, the modified Hodge test was a useful method for confirming carbapenemase production. Alternatively, a laboratory could confirm the carbapenemase with PCR for the blaKPC gene, which has the added benefit of confirming which enzyme is present.

It is important for laboratories to be vigilant about the identification of emerging KPC resistance in their institution. Strategies for laboratory identification of this resistance will likely have to be reviewed and adjusted as this mechanism is further investigated.


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: Centers for Disease Control and Prevention, Mail Stop G-08, 1600 Clifton Road NE, Atlanta, GA 30333. Phone: (404) 639-2824. Fax: (404) 639-1381. E-mail: ebi2{at}cdc.gov Back

{triangledown} Published ahead of print on 20 June 2007. Back


arrow
REFERENCES
 
    1
  1. Alba, J., Y. Ishii, K. Thomson, E. S. Moland, and K. Yamaguchi. 2005. Kinetics study of KPC-3, a plasmid-encoded class A carbapenem-hydrolyzing ß-lactamase. Antimicrob. Agents Chemother. 49:4760-4762.[Abstract/Free Full Text]
    2. 2
  2. Bradford, P. A., S. Bratu, C. Urban, M. Visalli, N. Mariano, D. Landman, J. J. Rahal, S. Brooks, S. Cebular, and J. Quale. 2004. Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 ß-lactamases in New York City. Clin. Infect. Dis. 39:55-60.[CrossRef][Medline]
    3. 3
  3. Bradford, P. A., C. Urban, N. Mariano, S. J. Projan, J. J. Rahal, and K. Bush. 1997. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC ß-lactamase, and the loss of an outer membrane protein. Antimicrob. Agents Chemother. 41:563-569.[Abstract]
    4. 4
  4. Bratu, S., D. Landman, M. Alam, E. Tolentino, and J. Quale. 2005. Detection of KPC carbapenem-hydrolyzing enzymes in Enterobacter spp. from Brooklyn, New York. Antimicrob. Agents Chemother. 49:776-778.[Abstract/Free Full Text]
    5. 5
  5. Bratu, S., M. Mooty, S. Nichani, D. Landman, C. Gullans, B. Pettinato, U. Karumudi, P. Tolaney, and J. Quale. 2005. Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: epidemiology and recommendations for detection. Antimicrob. Agents Chemother. 49:3018-3020.[Abstract/Free Full Text]
    6. 6
  6. Bush, K., and S. B. Singer. 1989. Effective cooling allows sonication to be used for liberation of ß-lactamases from gram-negative bacteria. J. Antimicrob. Chemother. 24:82-84.[Free Full Text]
    7. 7
  7. Clinical and Laboratory Standards Institute. 2006. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 7th ed. Approved standard M7-A7. Clinical and Laboratory Standards Institute, Wayne, PA.
    8. 8
  8. Clinical and Laboratory Standards Institute. 2006. Performance standards for antimicrobial disk susceptibility tests, 9th ed. Approved standard M2-A9. Clinical and Laboratory Standards Institute, Wayne, PA.
    9. 9
  9. Crowley, B., V. J. Benedi, and A. Domenech-Sanchez. 2002. Expression of SHV-2 ß-lactamase and of reduced amounts of OmpK36 porin in Klebsiella pneumoniae results in increased resistance to cephalosporins and carbapenems. Antimicrob. Agents Chemother. 46:3679-3682.[Abstract/Free Full Text]
    10. 10
  10. Deshpande, L. M., P. R. Rhomberg, H. S. Sader, and R. N. Jones. 2006. Emergence of serine carbapenemases (KPC and SME) among clinical strains of Enterobacteriaceae isolated in the United States medical centers: report from the MYSTIC program (1999-2005). Diagn. Microbiol. Infect. Dis. 56:367-372.[CrossRef][Medline]
    11. 11
  11. Hong, T., E. S. Moland, B. Abdalhamid, N. D. Hanson, J. Wang, C. Sloan, D. Fabian, A. Farajallah, J. Levine, and K. S. Thomson. 2005. Escherichia coli: development of carbapenem resistance during therapy. Clin. Infect. Dis. 40:e84-e86.[CrossRef][Medline]
    12. 12
  12. Hossain, A., M. J. Ferraro, R. M. Pino, R. B. Dew III, E. S. Moland, T. J. Lockhart, K. S. Thomson, R. V. Goering, and N. D. Hanson. 2004. Plasmid-mediated carbapenem-hydrolyzing enzyme KPC-2 in an Enterobacter sp. Antimicrob. Agents Chemother. 48:4438-4440.[Abstract/Free Full Text]
    13. 13
  13. Kaczmarek, F. M., F. Dib-Hajj, W. Shang, and T. D. Gootz. 2006. High-level carbapenem resistance in a Klebsiella pneumoniae clinical isolate is due to the combination of blaACT-1 ß-lactamase production, porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin PhoE. Antimicrob. Agents Chemother. 50:3396-3406.[Abstract/Free Full Text]
    14. 14
  14. Lee, K., Y. Chong, H. B. Shin, Y. A. Kim, D. Yong, and J. H. Yum. 2001. Modified Hodge and EDTA-disk synergy tests to screen metallo-ß-lactamase-producing strains of Pseudomonas and Acinetobacter species. Clin. Microbiol. Infect. 7:88-91.[CrossRef][Medline]
    15. 15
  15. Lomaestro, B. M., E. H. Tobin, W. Shang, and T. Gootz. 2006. The spread of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae to upstate New York. Clin. Infect. Dis. 43:e26-e28.[CrossRef][Medline]
    16. 16
  16. Matthew, M., and A. M. Harris. 1976. Identification of ß-lactamases by analytical isoelectric focusing: correlation with bacterial taxonomy. J. Gen. Microbiol. 94:55-67.[Abstract/Free Full Text]
    17. 17
  17. Miriagou, V., L. S. Tzouvelekis, S. Rossiter, E. Tzelepi, F. J. Angulo, and J. M. Whichard. 2003. Imipenem resistance in a Salmonella clinical strain due to plasmid-mediated class A carbapenemase KPC-2. Antimicrob. Agents Chemother. 47:1297-1300.[Abstract/Free Full Text]
    18. 18
  18. Naas, T., P. Nordmann, G. Vedel, and C. Poyart. 2005. Plasmid-mediated carbapenem-hydrolyzing ß-lactamase KPC in a Klebsiella pneumoniae isolate from France. Antimicrob. Agents Chemother. 49:4423-4424.[Free Full Text]
    19. 19
  19. Navon-Venezia, S., I. Chmelnitsky, A. Leavitt, M. J. Schwaber, D. Schwartz, and Y. Carmeli. 2006. Plasmid-mediated imipenem-hydrolyzing enzyme KPC-2 among multiple carbapenem-resistant Escherichia coli clones in Israel. Antimicrob. Agents Chemother. 50:3098-3101.[Abstract/Free Full Text]
    20. 20
  20. Perez-Perez, F. J., and N. D. Hanson. 2002. Detection of plasmid-mediated AmpC ß-lactamase genes in clinical isolates by using multiplex PCR. J. Clin. Microbiol. 40:2153-2162.[Abstract/Free Full Text]
    21. 21
  21. Smith Moland, E., N. D. Hanson, V. L. Herrera, J. A. Black, T. J. Lockhart, A. Hossain, J. A. Johnson, R. V. Goering, and K. S. Thomson. 2003. Plasmid-mediated, carbapenem-hydrolysing ß-lactamase, KPC-2, in Klebsiella pneumoniae isolates. J. Antimicrob. Chemother. 51:711-714.[Abstract/Free Full Text]
    22. 22
  22. Tenover, F. C., R. K. Kalsi, P. P. Williams, R. B. Carey, S. Stocker, D. Lonsway, J. K. Rasheed, J. W. Biddle, J. E. McGowan, Jr., and B. Hanna. 2006. Carbapenem resistance in Klebsiella pneumoniae not detected by automated susceptibility testing. Emerg. Infect. Dis. 12:1209-1213.[Medline]
    23. 23
  23. Villegas, M. V., K. Lolans, A. Correa, J. N. Kattan, J. A. Lopez, and J. P. Quinn. 2007. First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing ß-lactamase. Antimicrob. Agents Chemother. 51:1553-1555.[Abstract/Free Full Text]
    24. 24
  24. Villegas, M. V., K. Lolans, A. Correa, C. J. Suarez, J. A. Lopez, M. Vallejo, and J. P. Quinn. 2006. First detection of the plasmid-mediated class A carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America. Antimicrob. Agents Chemother. 50:2880-2882.[Abstract/Free Full Text]
    25. 25
  25. Woodford, N., J. W. Dallow, R. L. Hill, M. F. Palepou, R. Pike, M. E. Ward, M. Warner, and D. M. Livermore. 2007. Ertapenem resistance among Klebsiella and Enterobacter submitted in the UK to a reference laboratory. Int. J. Antimicrob. Agents 29:456-459.[CrossRef][Medline]
    26. 26
  26. Woodford, N., P. M. Tierno, Jr., K. Young, L. Tysall, M. F. Palepou, E. Ward, R. E. Painter, D. F. Suber, D. Shungu, L. L. Silver, K. Inglima, J. Kornblum, and D. M. Livermore. 2004. Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A ß-lactamase, KPC-3, in a New York medical center. Antimicrob. Agents Chemother. 48:4793-4799.[Abstract/Free Full Text]
    27. 27
  27. Yigit, H., A. M. Queenan, G. J. Anderson, A. Domenech-Sanchez, J. W. Biddle, C. D. Steward, S. Alberti, K. Bush, and F. C. Tenover. 2001. Novel carbapenem-hydrolyzing ß-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 45:1151-1161.[Abstract/Free Full Text]
    28. 28
  28. Yigit, H., A. M. Queenan, J. K. Rasheed, J. W. Biddle, A. Domenech-Sanchez, S. Alberti, K. Bush, and F. C. Tenover. 2003. Carbapenem-resistant strain of Klebsiella oxytoca harboring carbapenem-hydrolyzing ß-lactamase KPC-2. Antimicrob. Agents Chemother. 47:3881-3889.[Abstract/Free Full Text]

Journal of Clinical Microbiology, August 2007, p. 2723-2725, Vol. 45, No. 8
0095-1137/07/$08.00+0     doi:10.1128/JCM.00015-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Grobner, S., Linke, D., Schutz, W., Fladerer, C., Madlung, J., Autenrieth, I. B., Witte, W., Pfeifer, Y. (2009). Emergence of carbapenem-non-susceptible extended-spectrum {beta}-lactamase-producing Klebsiella pneumoniae isolates at the university hospital of Tubingen, Germany. J Med Microbiol 58: 912-922 [Abstract] [Full Text]  
  • Toye, B., Krajden, S., Fuksa, M., Low, D. E., Pillai, D. R. (2009). Carbapenem resistance in Canada. CMAJ 180: 1225-1226 [Full Text]  
  • Fisher, M. A., Stamper, P. D., Hujer, K. M., Love, Z., Croft, A., Cohen, S., Bonomo, R. A., Carroll, K. C., Petti, C. A. (2009). Performance of the Phoenix bacterial identification system compared with disc diffusion methods for identifying extended-spectrum {beta}-lactamase, AmpC and KPC producers. J Med Microbiol 58: 774-778 [Abstract] [Full Text]  
  • Gootz, T. D., Lescoe, M. K., Dib-Hajj, F., Dougherty, B. A., He, W., Della-Latta, P., Huard, R. C. (2009). Genetic Organization of Transposase Regions Surrounding blaKPC Carbapenemase Genes on Plasmids from Klebsiella Strains Isolated in a New York City Hospital. Antimicrob. Agents Chemother. 53: 1998-2004 [Abstract] [Full Text]  
  • McGettigan, S. E., Andreacchio, K., Edelstein, P. H. (2009). Specificity of Ertapenem Susceptibility Screening for Detection of Klebsiella pneumoniae Carbapenemases. J. Clin. Microbiol. 47: 785-786 [Abstract] [Full Text]  
  • Endimiani, A., Hujer, A. M., Perez, F., Bethel, C. R., Hujer, K. M., Kroeger, J., Oethinger, M., Paterson, D. L., Adams, M. D., Jacobs, M. R., Diekema, D. J., Hall, G. S., Jenkins, S. G., Rice, L. B., Tenover, F. C., Bonomo, R. A. (2009). Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA. J Antimicrob Chemother 63: 427-437 [Abstract] [Full Text]  
  • Peirano, G., Seki, L. M., Val Passos, V. L., Pinto, M. C. F. G., Guerra, L. R., Asensi, M. D. (2009). Carbapenem-hydrolysing {beta}-lactamase KPC-2 in Klebsiella pneumoniae isolated in Rio de Janeiro, Brazil. J Antimicrob Chemother 63: 265-268 [Abstract] [Full Text]  
  • Cole, J. M., Schuetz, A. N., Hill, C. E., Nolte, F. S. (2009). Development and Evaluation of a Real-Time PCR Assay for Detection of Klebsiella pneumoniae Carbapenemase Genes. J. Clin. Microbiol. 47: 322-326 [Abstract] [Full Text]  
  • Tsakris, A., Kristo, I., Poulou, A., Themeli-Digalaki, K., Ikonomidis, A., Petropoulou, D., Pournaras, S., Sofianou, D. (2009). Evaluation of Boronic Acid Disk Tests for Differentiating KPC-Possessing Klebsiella pneumoniae Isolates in the Clinical Laboratory. J. Clin. Microbiol. 47: 362-367 [Abstract] [Full Text]  
  • Bennett, J. W., Herrera, M. L., Lewis, J. S. II, Wickes, B. W., Jorgensen, J. H. (2009). KPC-2-Producing Enterobacter cloacae and Pseudomonas putida Coinfection in a Liver Transplant Recipient. Antimicrob. Agents Chemother. 53: 292-294 [Abstract] [Full Text]  
  • Tsakris, A., Kristo, I., Poulou, A., Markou, F., Ikonomidis, A., Pournaras, S. (2008). First occurrence of KPC-2-possessing Klebsiella pneumoniae in a Greek hospital and recommendation for detection with boronic acid disc tests. J Antimicrob Chemother 62: 1257-1260 [Abstract] [Full Text]  
  • Doi, Y., Potoski, B. A., Adams-Haduch, J. M., Sidjabat, H. E., Pasculle, A. W., Paterson, D. L. (2008). Simple Disk-Based Method for Detection of Klebsiella pneumoniae Carbapenemase-Type {beta}-Lactamase by Use of a Boronic Acid Compound. J. Clin. Microbiol. 46: 4083-4086 [Abstract] [Full Text]  
  • Petrella, S., Ziental-Gelus, N., Mayer, C., Renard, M., Jarlier, V., Sougakoff, W. (2008). Genetic and Structural Insights into the Dissemination Potential of the Extremely Broad-Spectrum Class A {beta}-Lactamase KPC-2 Identified in an Escherichia coli Strain and an Enterobacter cloacae Strain Isolated from the Same Patient in France. Antimicrob. Agents Chemother. 52: 3725-3736 [Abstract] [Full Text]  
  • Hindiyeh, M., Smollen, G., Grossman, Z., Ram, D., Davidson, Y., Mileguir, F., Vax, M., Ben David, D., Tal, I., Rahav, G., Shamiss, A., Mendelson, E., Keller, N. (2008). Rapid Detection of blaKPC Carbapenemase Genes by Real-Time PCR. J. Clin. Microbiol. 46: 2879-2883 [Abstract] [Full Text]  
  • Tibbetts, R., Frye, J. G., Marschall, J., Warren, D., Dunne, W. (2008). Detection of KPC-2 in a Clinical Isolate of Proteus mirabilis and First Reported Description of Carbapenemase Resistance Caused by a KPC {beta}-Lactamase in P. mirabilis. J. Clin. Microbiol. 46: 3080-3083 [Abstract] [Full Text]  
  • Rasheed, J. K., Biddle, J. W., Anderson, K. F., Washer, L., Chenoweth, C., Perrin, J., Newton, D. W., Patel, J. B. (2008). Detection of the Klebsiella pneumoniae Carbapenemase Type 2 Carbapenem-Hydrolyzing Enzyme in Clinical Isolates of Citrobacter freundii and K. oxytoca Carrying a Common Plasmid. J. Clin. Microbiol. 46: 2066-2069 [Abstract] [Full Text]  
  • Aschbacher, R., Doumith, M., Livermore, D. M., Larcher, C., Woodford, N. (2008). Linkage of acquired quinolone resistance (qnrS1) and metallo-{beta}-lactamase (blaVIM-1) genes in multiple species of Enterobacteriaceae from Bolzano, Italy. J Antimicrob Chemother 61: 515-523 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Anderson, K. F.
Right arrow Articles by Patel, J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Anderson, K. F.
Right arrow Articles by Patel, J. B.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»